Cementless Ankle Replacement Gets FDA Nod

The U.S. Food and Drug Administration (FDA) has approved a cementless ankle replacement system for arthritic ankles that is designed to preserve range of motion in the joint. The new prosthesis, called the Scandinavian Total Ankle Replacement (STAR) System and produced by Small Bone Innovations Inc. (SBI), is a mobile-bearing, three-component design consisting of individual tibial (shin bone) and talar (ankle bone) implants separated by a mobile polyethylene spacer. It is claimed to allow more movement in the joint and result in less wear and loosening than other devices. It is designed as an alternative to fusion surgery, which involves cementing the tibia to the talus. Fusion stabilizes the ankle, but decreases the ability to move the foot up and down.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Arthritis Advisor

Get the next year of Arthritis Advisor for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 36%. It's like getting 4 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access